Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2024.1393692 Medicine Correction Expression of concern on: Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) variant of concern from Amazonas, Brazil Frontiers Editorial Office *

Approved by: Frontiers in Medicine Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Frontiers Editorial Office research.integrity@frontiersin.org 26 03 2024 2024 11 1393692 29 02 2024 11 03 2024 Copyright © 2024 Frontiers Editorial Office. 2024 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Expression of Concern on Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) variant of concern from Amazonas, Brazil by Zimerman, R. A., Ferrareze, P. A. G., Cadegiani, F. A., Wambier, C. G., Fonseca, D. d. N., de Souza, A. R., Goren, A., Rotta, L. N., Ren, Z., and Thompson, C. E. (2022). Front. Med. 9:806611. doi: 10.3389/fmed.2022.806611 section-at-acceptance Infectious Diseases: Pathogenesis and Therapy

With this notice, Frontiers states its awareness of ethics concerns surrounding the article “Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil” published on 15 February 2022. An investigation is currently being conducted by The Federal University of Health Sciences of Porto Alegre, in accordance with applicable institutional policies and procedures. This expression of concern has been posted while Frontiers awaits the outcome of that investigation. It will be updated accordingly after that time.